Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Nuclear receptor ROR-gamma | ||
Ligand | BDBM362840 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Binding Assay | ||
Ki | <100±n/a nM | ||
Citation | Claremon, DA; Dillard, LW; Dong, C; Fan, Y; Jia, L; Lotesta, SD; Marcus, A; Singh, SB; Tice, CM; Yuan, J; Zhao, W; Zheng, Y; Zhuang, L Isoindoline inhibitors of ROR-gamma US Patent US9845308 Publication Date 12/19/2017 | ||
More Info.: | Get all data from this article, Assay Method | ||
Nuclear receptor ROR-gamma | |||
Name: | Nuclear receptor ROR-gamma | ||
Synonyms: | NR1F3 | Nuclear receptor ROR-gamma | Nuclear receptor ROR-gamma (RORC) | Nuclear receptor subfamily 1 group F member 3 | RAR-related orphan receptor C (RORc) | RORC | RORG | RORG_HUMAN | RZRG | Retinoid-related orphan receptor-gamma | Retinoid-related orphan receptor-gamma (RORc) | ||
Type: | Enzyme Catalytic Domain | ||
Mol. Mass.: | 58218.40 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P51449 | ||
Residue: | 518 | ||
Sequence: |
| ||
BDBM362840 | |||
n/a | |||
Name | BDBM362840 | ||
Synonyms: | N-((5-(ethylsulfonyl)pyridin-2-yl)methyl)-1-isopropyl-2-((trans-4-(trifluoromethyl)cyclohexyl)methyl)isoindoline-5-carboxamide (1a) and (1b) | US9845308, Example 1a | ||
Type | Small organic molecule | ||
Emp. Form. | C28H36F3N3O3S | ||
Mol. Mass. | 551.664 | ||
SMILES | CCS(=O)(=O)c1ccc(CNC(=O)c2ccc3[C@H](C(C)C)N(C[C@H]4CC[C@@H](CC4)C(F)(F)F)Cc3c2)nc1 |r,wU:26.29,wD:17.17,23.22,(11.55,4.09,;10.21,3.32,;8.88,4.09,;8.11,2.76,;9.65,5.43,;7.54,4.86,;7.5,6.43,;6.16,7.2,;4.83,6.43,;3.49,7.2,;2.16,6.43,;.83,7.2,;.83,8.74,;-.51,6.43,;-.51,4.89,;-1.84,4.12,;-3.17,4.89,;-4.64,4.41,;-5.04,2.93,;-6.52,2.53,;-3.95,1.84,;-5.54,5.66,;-7.08,5.66,;-7.85,6.99,;-7.08,8.33,;-7.85,9.66,;-9.39,9.66,;-10.16,8.33,;-9.39,6.99,;-10.16,10.99,;-9.39,12.33,;-11.7,10.99,;-10.93,12.33,;-4.64,6.91,;-3.17,6.43,;-1.84,7.2,;4.83,4.89,;6.16,4.12,)| | ||
Structure |